Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 28, 2019; 25(32): 4764-4778
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4764
Published online Aug 28, 2019. doi: 10.3748/wjg.v25.i32.4764
Figure 1 Flow chart of study population.
ETV: Entecavir; PLC: Placebo; RGT: Biejia-ruangan tablet; HCC: Hepatocellular carcinoma.
- Citation: Chang XJ, Sun C, Chen Y, Li XD, Yu ZJ, Dong Z, Bai WL, Wang XD, Li ZQ, Chen D, Du WJ, Liao H, Jiang QY, Sun LJ, Li YY, Zhang CH, Xu DP, Chen YP, Li Q, Yang YP. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B. World J Gastroenterol 2019; 25(32): 4764-4778
- URL: https://www.wjgnet.com/1007-9327/full/v25/i32/4764.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i32.4764